DIO Corporation (KOSDAQ:039840)
17,840
+550 (3.18%)
At close: Feb 27, 2026
DIO Corporation Market Cap
DIO Corporation has a market cap or net worth of 238.86 billion as of February 27, 2026. Its market cap has decreased by -0.84% in one year.
Market Cap
238.86B
Enterprise Value
275.34B
Revenue
155.15B
Ranking
n/a
PE Ratio
40.58
Stock Price
17,840.00
Market Cap Chart
Since March 1, 2001, DIO Corporation's market cap has increased from 25.42B to 238.86B, an increase of 839.60%. That is a compound annual growth rate of 9.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 238.86B | 5.62% |
| Dec 30, 2025 | 226.14B | 1.27% |
| Dec 30, 2024 | 223.31B | -31.36% |
| Dec 28, 2023 | 325.35B | 11.83% |
| Dec 29, 2022 | 290.93B | -47.39% |
| Dec 30, 2021 | 553.05B | 17.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.31T |
| Celltrion | 52.20T |
| ALTEOGEN | 21.79T |
| Sam Chun Dang Pharm. | 19.19T |
| Daewon Pharmaceutical | 244.98B |
| EASY BIO,Inc. | 242.49B |
| Samil Pharmaceutical Co.,Ltd | 237.35B |
| HLB Therapeutics | 235.50B |